Trump receives experimental coronavirus treatment as drug companies seek the right approach to mild and moderate forms of COVID-19
President Donald Trump, who recently tested positive for the coronavirus, has been given a dose of Regeneron Pharmaceuticals Inc.’s experimental neutralizing antibody cocktail, which is currently being tested in clinical trials for non-hospitalized COVID-19 patients.
